| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-10 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |